NO970174L - 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner - Google Patents

2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner

Info

Publication number
NO970174L
NO970174L NO970174A NO970174A NO970174L NO 970174 L NO970174 L NO 970174L NO 970174 A NO970174 A NO 970174A NO 970174 A NO970174 A NO 970174A NO 970174 L NO970174 L NO 970174L
Authority
NO
Norway
Prior art keywords
carbon atoms
straight chain
dihydroquinolinyl
oxazolidinones
thio
Prior art date
Application number
NO970174A
Other languages
English (en)
Other versions
NO970174D0 (no
Inventor
Dieter Haebich
Andreas Stolle
Bernd Riedl
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO970174D0 publication Critical patent/NO970174D0/no
Publication of NO970174L publication Critical patent/NO970174L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Det blir beskrevet 2-okso- og 2-tio-l,2-dihydrochinoli- nyl-oksazolidinoner med den generelle formel (I) (I), hvor A står for et oksygen- eller svovelatom, D står for hydrogen eller for cykloalkyl med 3 til 6 karbonatomer, eller rettkjedet eller forgrenet alkoksykarbonyl med opp til 4 karbonatomer, eller eventuelt substituert rettkjedet eller forgrenet alkyl eller alkenyl med opp til 9 karbonatomer, eller for eventuelt substituert rettkjedet eller forgrenet acyl med opp til 5 karbonatomer, eller for en av gruppene med formelene -( CT )jj-NR10r11 , -( C0)c-NR^2-C0-Nr13r14 _ -Nr15-S02R^^, r1'7r18-N-S02-, 51*^-5(0);, eller -C0-R20 , E og L er like eller forskjellige og står for hydrogen, karboksy, halogen, cyano, formyl, trifluormetyl, nitro eller rettkjedet eller forgrenet alkyl med opp til 4 karbonatomer, R^ står for azido, hydroksy, eller for en gruppe med formel -OR^l, O-SOaR^^ eller -KR^SrS"! ^ og deres salter og isomerer. Det blir dessuten beskrevet en fremgangsmåte for fremstilling av forbindelsene samt deres anvendelse i legemidler, spesielt i antibakterielle legemidler.
NO970174A 1996-01-16 1997-01-15 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner NO970174L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (2)

Publication Number Publication Date
NO970174D0 NO970174D0 (no) 1997-01-15
NO970174L true NO970174L (no) 1997-07-17

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970174A NO970174L (no) 1996-01-16 1997-01-15 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner

Country Status (28)

Country Link
US (1) US5861413A (no)
EP (1) EP0785197A3 (no)
JP (1) JPH09194478A (no)
KR (1) KR970059174A (no)
AR (1) AR005458A1 (no)
AU (1) AU711924B2 (no)
BG (1) BG62257B1 (no)
BR (1) BR9700688A (no)
CA (1) CA2194945A1 (no)
CO (1) CO4520188A1 (no)
CZ (1) CZ12897A3 (no)
DE (1) DE19601265A1 (no)
EE (1) EE9700019A (no)
HN (1) HN1996000124A (no)
HR (1) HRP960614A2 (no)
HU (1) HUP9700126A3 (no)
IL (1) IL119994A0 (no)
NO (1) NO970174L (no)
NZ (1) NZ314057A (no)
PE (1) PE35398A1 (no)
PL (1) PL317930A1 (no)
SG (1) SG46764A1 (no)
SK (1) SK5897A3 (no)
SV (1) SV1997000002A (no)
TN (1) TNSN97009A1 (no)
TR (1) TR199601002A1 (no)
YU (1) YU1097A (no)
ZA (1) ZA97302B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
EP1082323A2 (en) * 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE60112581T2 (de) 2000-06-30 2006-06-01 Pharmacia & Upjohn Co. Llc, Kalamazoo Zusammensetzungen zur Behandlung bakterieller Infektionen, welche ein Oxazolidinonderivat, Sulbactam und Ampicillin enthalten
EP1349853B1 (en) 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
MXPA05001558A (es) * 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
WO2004026848A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
ATE344036T1 (de) * 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE60324179D1 (de) * 2002-12-04 2008-11-27 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
CA2515311A1 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりｎ−置換されたオキサゾリジノン誘導体
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
MXPA05011654A (es) 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
ES2310299T5 (es) 2003-12-18 2014-02-10 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibióticos híbridos a base de oxazolidinona-quinolona
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
CA2713187C (en) * 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
US10160726B2 (en) * 2014-08-06 2018-12-25 Novartis Ag Quinolone derivatives as antibacterials
KR102943446B1 (ko) * 2020-10-26 2026-04-01 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ES2157934T3 (es) 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
JP2669579B2 (ja) 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (no) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
CO4520188A1 (es) 1997-10-15
TR199601002A1 (tr) 1997-08-21
BG62257B1 (bg) 1999-06-30
MX9700419A (es) 1997-07-31
HUP9700126A2 (hu) 1998-12-28
KR970059174A (ko) 1997-08-12
SV1997000002A (es) 1997-08-29
HU9700126D0 (en) 1997-02-28
AR005458A1 (es) 1999-06-23
NZ314057A (en) 1998-11-25
BR9700688A (pt) 1998-09-01
HRP960614A2 (en) 1998-02-28
AU711924B2 (en) 1999-10-21
EP0785197A3 (de) 1999-02-10
AU1009797A (en) 1997-07-24
YU1097A (sh) 1999-12-27
SG46764A1 (en) 1998-02-20
TNSN97009A1 (fr) 2005-03-15
HUP9700126A3 (en) 1999-05-28
PE35398A1 (es) 1998-08-29
NO970174D0 (no) 1997-01-15
SK5897A3 (en) 1997-09-10
HN1996000124A (es) 1997-06-18
BG101131A (en) 1998-04-30
EE9700019A (et) 1997-08-15
IL119994A0 (en) 1997-04-15
JPH09194478A (ja) 1997-07-29
DE19601265A1 (de) 1997-07-17
PL317930A1 (en) 1997-07-21
ZA97302B (en) 1997-07-17
EP0785197A2 (de) 1997-07-23
CA2194945A1 (en) 1997-07-17
CZ12897A3 (en) 1997-08-13
US5861413A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
AU584663B2 (en) Thieno-triazolo-1,4-diazepino-2-carboxylic acid amides
KR100263496B1 (ko) 탁솔 유도체 및 이의 제조방법
GB9508195D0 (en) Novel biologically active compounds and compositions,their use and derivation
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
AU6613896A (en) Chemical compounds
PE20001225A1 (es) Derivados de adenina
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
MX9710218A (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
DE69308029D1 (de) 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA
TR200103683T2 (tr) Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı
CA2247167A1 (en) 2-hetaroylcyclohexane-1,3-diones
DE3869173D1 (de) Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
NO982778D0 (no) Morfinderivater med smertestillende virkning
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
GB9711123D0 (en) Novel cyanoguanidines
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
NO941516L (no) 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
BR0014687A (pt) Compostos de taxano pentacìclico
DE69819695D1 (en) Benzimidazolderivate
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
ATE179170T1 (de) 3-substituierte pyridinverbindungen und deren derivate als herbizide
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen